ADPT Quote, Trading Chart, Adeptus Health
home / stock / adpt / adpt quote
$ Last:
Change Percent:
$ Open:
$ Previous Close:
$ High:
$ Low:
0 Volume:
01/01/1970 12:00:00 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-03-01 | 56.95 | 57.89 | 59.09 | 56.95 | 656,358 |
| 2021-02-26 | 56.65 | 56.57 | 57.39 | 53.65 | 685,951 |
| 2021-02-25 | 55.04 | 55.31 | 57.99 | 53.955 | 1,622,844 |
| 2021-02-24 | 57 | 58.39 | 59.71 | 55.86 | 665,371 |
| 2021-02-23 | 56 | 56.76 | 57.44 | 52.66 | 912,410 |
| 2021-02-22 | 62.34 | 56.72 | 62.34 | 56.41 | 868,594 |
| 2021-02-19 | 61.39 | 63.21 | 64.33 | 60.84 | 641,912 |
| 2021-02-18 | 61.21 | 61.3 | 62.12 | 59.58 | 441,815 |
| 2021-02-17 | 62.92 | 62.12 | 63.985 | 60.94 | 595,576 |
| 2021-02-16 | 65.45 | 64.21 | 65.725 | 62.6 | 521,369 |
| 2021-02-15 | 64.96 | 66.5 | 67.34 | 63.93 | 579,157 |
| 2021-02-12 | 64.96 | 66.5 | 67.34 | 63.93 | 577,710 |
| 2021-02-11 | 63.24 | 64.37 | 64.59 | 62.51 | 508,587 |
| 2021-02-10 | 63.25 | 62.78 | 64.93 | 60.8005 | 415,072 |
| 2021-02-09 | 61.55 | 62.15 | 63.7094 | 61.34 | 347,892 |
| 2021-02-08 | 61.98 | 61.36 | 62.8369 | 60.81 | 595,746 |
| 2021-02-05 | 59.91 | 61.36 | 62.06 | 58.9 | 424,295 |
| 2021-02-04 | 59.59 | 59.31 | 60.07 | 58.01 | 386,056 |
| 2021-02-03 | 60.62 | 59.62 | 61.9145 | 58.79 | 497,178 |
| 2021-02-02 | 57.88 | 60.39 | 60.87 | 57.47 | 1,136,686 |
News, Short Squeeze, Breakout and More Instantly...
-
SEATTLE, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be particip...
-
Image source: The Motley Fool. Adaptive Biotechnologies Corporation (NASDAQ: ADPT) Q4 2020 Earnings Call Feb 24, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Adaptive Biotechnologies Corporation (ADPT) Q4 2020 Ea...
-
SEATTLE, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation ("Adaptive Biotechnologies") (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today...
Important Investor News Alert (OTCMKTS: GTCH)
-
SAN DIEGO, March 02, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. ( OTC PINK: GTCH ) ("GBT” or the “Company”), is continuing its research with AI based, robotics technology for the medical field. The research is now focused on remote operation robotics fo...